25th Oct 2006 16:08
Celsis International PLC25 October 2006 CELSIS INTERNATIONAL PLC NOTIFICATION OF RESULTS 25 October 2006: Celsis International plc, the life sciences products andservices company, will announce its interim results for the six months ended 30September 2006 on Wednesday 8 November 2006. There will be a presentation to analysts on the day at 9.30am, held at FinancialDynamics, Holborn Gate, 26 Southampton Buildings, London, WC2A 1PB. Enquiries: Celsis International plc Tel: 01638 600 153Jay LeCoque, Chief Executive OfficerJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113Anna KeebleBen Atwell Notes to editors Celsis International plc Celsis International plc provides value enhancing products and services to thepharmaceutical, biopharmaceutical, and consumer products industries through itsthree business areas; rapid detection, analytical services and in vitrodiagnostics. The company is listed on the London Stock Exchange (CEL.L). In addition to ensuring product quality and safety for consumers, each divisionhas the capacity to deliver substantial cost savings to Celsis' customers.Using proprietary technology, the rapid detection business is the world leaderin the provision of diagnostic systems for the rapid detection of contamination.By reducing the time it takes to test and release raw materials and finishedgoods to the market place, Celsis technology facilitates increased manufacturingproductivity and improved supply chain management. The analytical servicesdivision provides outsourced laboratory testing services to pharmaceutical andbiopharmaceutical companies to ensure the stability and chemical composition oftheir products. In Vitro Technologies (IVT) supplies in vitro testing productsand services to the pharmaceutical and biotechnology industries. IVT's in vitroproducts and services screen drug compounds early in the discovery process,thereby reducing the time and cost of drug development. Further information can be found on its website at www.celsis.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Celadon Pharmaceuticals